journal
Journals Journal of the Pediatric Infec...

Journal of the Pediatric Infectious Diseases Society

https://read.qxmd.com/read/38780125/risk-factors-for-pediatric-critical-covid-19-a-systematic-review-and-meta-analysis
#1
JOURNAL ARTICLE
Camila Aparicio, Zachary I Willis, Mari M Nakamura, Joshua Wolf, Cordell Little, Gabriela M Maron, Paul K Sue, Brenda I Anosike, Christine Miller, Laura L Bio, Prachi Singh, Scott H James, Carlos R Oliveira
BACKGROUND: Risk stratification is a cornerstone of the Pediatric Infectious Diseases Society COVID-19 treatment guidance. This systematic review and meta-analysis aimed to define the clinical characteristics and comorbidities associated with critical COVID-19 in children and adolescents. METHODS: Two independent reviewers screened the literature (Medline and EMBASE) for studies published through August 31, 2023, that reported outcome data on patients aged ≤21 years with COVID-19...
May 23, 2024: Journal of the Pediatric Infectious Diseases Society
https://read.qxmd.com/read/38779958/early-impact-of-nirsevimab-on-ambulatory-all-cause-bronchiolitis-a-prospective-multicentric-surveillance-study-in-france
#2
JOURNAL ARTICLE
Corinne Levy, Andreas Werner, Alexis Rybak, Stéphane Béchet, Christophe Batard, Frédéric Hassid, Roxane Desandes, Bruno Frandji, Naim Ouldali, Robert Cohen
After implementation of nirsevimab in 2023 in France as compared with 2022-2023, we found a 52.7%, 95% CI [46.4-58.9]) decrease in all-cause bronchiolitis in children <3 months with the lowest number of bronchiolitis cases in this population since 2017.
May 23, 2024: Journal of the Pediatric Infectious Diseases Society
https://read.qxmd.com/read/38761121/utilization-of-telemedicine-for-evaluation-of-patients-and-distribution-of-a-scarce-resource-during-the-covid-19-pandemic
#3
JOURNAL ARTICLE
Kathryn Weakley, Kristina Bryant
No abstract text is available yet for this article.
May 18, 2024: Journal of the Pediatric Infectious Diseases Society
https://read.qxmd.com/read/38761052/cost-effectiveness-of-pediatric-conjunctivitis-management-and-return-to-childcare-and-school-strategies-a-comparative-study
#4
JOURNAL ARTICLE
Holly M Frost, Amy B Stein, Amy Keith, Timothy C Jenkins
BACKGROUND: Infectious conjunctivitis affects one in eight children annually, resulting in high ophthalmic antibiotic prescribing and absenteeism from childcare and school. We aimed to quantify the cost-effectiveness and annual savings of three evidence-based approaches to conjunctivitis management and return to childcare and school compared to usual care. METHODS: Using a decision analytic model from a societal perspective over a one-year time horizon, we conducted a cost-effectiveness analysis of three management strategies for children aged 6 months-17 years with non-severe conjunctivitis compared to usual care in the United States...
May 18, 2024: Journal of the Pediatric Infectious Diseases Society
https://read.qxmd.com/read/38758203/introduction-to-the-healthcare-sustainability-supplement
#5
JOURNAL ARTICLE
Shreya M Doshi, Preeti Jaggi
No abstract text is available yet for this article.
May 17, 2024: Journal of the Pediatric Infectious Diseases Society
https://read.qxmd.com/read/38758197/healthcare-sustainability-to-address-climate-change-call-for-action-to-the-infectious-diseases-community
#6
JOURNAL ARTICLE
Shreya Doshi, Sharon Vuppula, Preeti Jaggi
The U.S. healthcare system's contribution to greenhouse gas emissions and climate change is disproportionately high and harms the public. Several medical specialties are now reassessing how they can mitigate healthcare's harmful environmental impact. Healthcare sustainability is broadly defined as measures to decrease greenhouse gas emissions, waste, and other pollutants generated during the healthcare delivery process. Prior efforts and programs by infectious diseases (ID) professionals, such as antimicrobial stewardship and infection prevention and control can form a framework for ID professionals to help apply this expertise to healthcare environmental sustainability more broadly...
May 17, 2024: Journal of the Pediatric Infectious Diseases Society
https://read.qxmd.com/read/38738667/the-effect-of-ophthalmic-antibiotics-on-clinical-outcomes-and-transmissibility-of-conjunctivitis-associated-with-h-influenzae-vs-other-pathogens-secondary-analysis-of-a-randomized-controlled-trial
#7
JOURNAL ARTICLE
Elizabeth T Thomas, Rafael Perera-Salazar, Holly M Frost
No abstract text is available yet for this article.
May 13, 2024: Journal of the Pediatric Infectious Diseases Society
https://read.qxmd.com/read/38738450/risk-analysis-of-respiratory-syncytial-virus-among-infants-in-the-united-states-by-birth-month
#8
JOURNAL ARTICLE
Jason R Gantenberg, Robertus van Aalst, Monika Reddy Bhuma, Brendan Limone, David Diakun, David M Smith, Christopher B Nelson, Angela M Bengtson, Sandra S Chaves, William V La Via, Christopher Rizzo, David A Savitz, Andrew R Zullo
BACKGROUND: Respiratory syncytial virus (RSV) is a major cause of morbidity and mortality among U.S. infants. A child's calendar birth month determines their age at first exposure(s) to RSV. We estimated birth month-specific risk of medically attended (MA) RSV lower respiratory tract infection (LRTI) among infants during their first RSV season and first year of life. METHODS: We analyzed infants born in the USA between July 2016 and February 2020 using three insurance claims databases (two commercial, one Medicaid)...
May 13, 2024: Journal of the Pediatric Infectious Diseases Society
https://read.qxmd.com/read/38717105/enteric-fever-in-children-an-epidemiological-and-clinical-review-of-cases-in-southeast-texas
#9
JOURNAL ARTICLE
Zachary C Foughty, Denver T Niles, Andrea T Cruz
Extensively drug-resistant (XDR) strains of Salmonella enterica serotype Typhi have emerged in Pakistan and Iraq. We report 13 children with enteric fever in Southeast Texas seen over 3.5 years, of whom 23.1% had XDR isolates.
May 8, 2024: Journal of the Pediatric Infectious Diseases Society
https://read.qxmd.com/read/38715418/evidence-still-pending-post-exposure-prophylactic-measures-against-varicella-zoster-virus
#10
JOURNAL ARTICLE
Hideharu Hagiya, Shinnosuke Fukushima
No abstract text is available yet for this article.
May 8, 2024: Journal of the Pediatric Infectious Diseases Society
https://read.qxmd.com/read/38686824/opportunities-and-barriers-to-pediatric-antimicrobial-stewardship-by-community-pharmacists
#11
JOURNAL ARTICLE
Shahd Alzard, Jane Wen, Nguyen Phuong Quynh Huynh, Shahrzad Shirkhanzadeh, Jocelyn Y Tso, Meynard Rabino, Marijana Vanevski, Penelope A Bryant, Jim Buttery, Gabrielle M Haeusler, Angelina S Lim
Community Pharmacists (CPs) are easily accessible and can advocate for appropriate use of antibiotics in children. Semi-structured interviews were conducted with 47 CPs and 46 parents/caregivers. Both groups expressed challenges to intervening when antibiotics have already been prescribed and highlighted the need for more support for CPs to make informed decisions.
April 30, 2024: Journal of the Pediatric Infectious Diseases Society
https://read.qxmd.com/read/38644605/plasma-metagenomic-sequencing-in-immunocompromised-children-a-call-for-caution-in-the-interpretation-of-results
#12
JOURNAL ARTICLE
Sandra Castejon-Ramirez, Heather L Glasgow, Jose A Ferrolino, Randall T Hayden, Gabriela Maron, Diego R Hijano
No abstract text is available yet for this article.
April 22, 2024: Journal of the Pediatric Infectious Diseases Society
https://read.qxmd.com/read/38606511/neonatal-herpes-reporting-in-the-united-states-review-of-current-policies-by-state
#13
JOURNAL ARTICLE
Natalie Saremi, Katherine A Lewis, Jeffrey D Klausner
No abstract text is available yet for this article.
April 12, 2024: Journal of the Pediatric Infectious Diseases Society
https://read.qxmd.com/read/38597677/georges-peter-md-1938-2024
#14
JOURNAL ARTICLE
Stanley Plotkin
No abstract text is available yet for this article.
April 10, 2024: Journal of the Pediatric Infectious Diseases Society
https://read.qxmd.com/read/38591356/off-label-use-of-long-acting-injectable-antiretroviral-therapy-a-single-center-retrospective-review-of-youth-living-with-hiv-with-detectable-hiv-rna-starting-injectable-therapy
#15
JOURNAL ARTICLE
Alison Rousseau, Eric McGrath, Laura Benjamins, Salome Cockern, Jill Meade, Keshaum Houston, Melina Breaux, Elizabeth Secord
Nineteen youth living with HIV (YLWH) opted for injectable cabotegravir and rilpivirine without oral lead in and without achieving an undetectable HIV viral load (VL) for the 3 months prior to initiation. All achieved undetectable status within 3 months (3 injections) and maintained an undetectable status through 6-12 months of therapy.
April 9, 2024: Journal of the Pediatric Infectious Diseases Society
https://read.qxmd.com/read/38588463/-where-did-this-come-from-antibiotic-prophylaxis-in-biliary-atresia-after-kasai-procedure
#16
JOURNAL ARTICLE
Naseem Ravanbakhsh, Catherine A Chapin, Yun Li, Ravi Jhaveri
For patients with Biliary atresia, antibiotic prophylaxis after Kasai portoenterostomy is a common practice. Societal guidelines often cite one reference as supportive evidence for this practice. In this paper, we go back to review the quality of this evidence and suggest more research is required to demonstrate the efficacy of antibiotic prophylaxis in this population.
April 8, 2024: Journal of the Pediatric Infectious Diseases Society
https://read.qxmd.com/read/38587478/school-based-mobile-clinics-to-improve-vaccine-access-a-cross-sectional-study-of-covid-19-vaccination
#17
JOURNAL ARTICLE
Amir M Mohareb, Miriam Deukmejian, Cesar Guerra Castillo, Tyler S Brown, Regina LaRocque, Elsie Taveras, Priya Sarin Gupta
No abstract text is available yet for this article.
April 8, 2024: Journal of the Pediatric Infectious Diseases Society
https://read.qxmd.com/read/38581154/-give-me-five-the-case-for-5-days-of-antibiotics-as-the-default-duration-for-acute-respiratory-tract-infections
#18
JOURNAL ARTICLE
Rana E El Feghaly, Preeti Jaggi, Sophie E Katz, Nicole M Poole
Acute respiratory tract infections (ARTIs) account for most antibiotic prescriptions in pediatrics. Although US guidelines continue to recommend ≥10 days antibiotics for common ARTIs, evidence suggests that 5-day courses can be safe and effective. Academic imprinting seems to play a major role in the continued use of prolonged antibiotic durations. In this report, we discuss the evidence supporting short antibiotic courses for group A streptococcal pharyngitis, acute otitis media, and acute bacterial rhinosinusitis...
April 6, 2024: Journal of the Pediatric Infectious Diseases Society
https://read.qxmd.com/read/38577737/a-historical-perspective-on-rsv-prevention-a-journey-spanning-over-half-a-century-from-the-setback-of-an-inactive-vaccine-candidate-to-the-success-of-passive-immunization-strategy
#19
JOURNAL ARTICLE
Asif Noor, Leonard R Krilov
The efforts to prevent RSV infection in infants span over half a century. RSV vaccine development began in the 1960s, and it confronted a significant disappointment after testing a formalin inactivated RSV (FI RSV) vaccine candidate. This inactivated RSV vaccine was not protective. A large number of the vaccinated RSV naïve children, when subsequently exposed to natural RSV infection from wild type virus in the community, developed severe lung inflammation termed enhanced respiratory disease. This resulted in a halt in RSV vaccine development...
April 5, 2024: Journal of the Pediatric Infectious Diseases Society
https://read.qxmd.com/read/38554101/new-and-emerging-passive-immunization-strategies-for-the-prevention-of-rsv-infection-during-infancy
#20
JOURNAL ARTICLE
Joseph B Domachowske
To date, safe and effective strategies to prevent medically attended RSV illness across the infant population have been limited to passive immunoprophylaxis for those at highest risk. While active vaccination strategies are finally available to protect adults 60 years and older from serious RSV infection, safe and effective vaccines for use in children have yet to emerge. In contrast, passive immunization strategies designed to protect all infants against RSV has finally met with success, with two new strategies approved by the United States Food and Drug Administration during the second half of 2023...
March 30, 2024: Journal of the Pediatric Infectious Diseases Society
journal
journal
47483
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.